Cognitive Enhancement and Beyond: Recommendations from the Bioethics Commission

Trends in Cognitive Sciences

Volumn 19, Issue 10, 2015, Pages 549-551

  Allen, Anita L ^a,b   Strand, Nicolle K ^a  

^a Presidential Commission for the Study of Bioethical Issues   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALERTNESS; ATTENTION; BIOETHICS; BRAIN INJURY; CEREBROVASCULAR ACCIDENT; COGNITION; COGNITIVE ENHANCEMENT; DIET SUPPLEMENTATION; HUMAN; MEMORY; NOTE; PERSONALITY; SLEEP; SLEEP DISORDER; TRANSCRANIAL DIRECT CURRENT STIMULATION; TRANSCRANIAL MAGNETIC STIMULATION; COGNITIVE THERAPY; DRUG EFFECTS; ETHICS; PHYSIOLOGY; PROCEDURES; PSYCHOLOGY;

BIOETHICS; COGNITION; COGNITIVE SCIENCE; COGNITIVE THERAPY; HUMANS;

EID: 84942099945     PISSN: 13646613     EISSN: 1879307X     Source Type: Journal    
DOI: 10.1016/j.tics.2015.08.001     Document Type: Note

References (8)

1. Presidential Commission for the Study of Bioethical Issues Gray Matters: Topics at the Intersection of Neuroscience, Ethics, and Society 2015, Presidential Commission for the Study of Bioethical Issues.
2. Allhoff F., et al. Ethics of human enhancement: an executive summary. Sci. Eng. Ethics 2011, 17:201-212.
3. Schwarz A. Workers seeking productivity in a pill are abusing ADHD drugs. New York Times 2015, 18 April.
4. Repantis D., et al. Modafinil and methylphenidate for neuroenhancement in healthy individuals: a systematic review. Pharmacol. Res. 2010, 62:187-206.
5. Cakic V. Smart drugs for cognitive enhancement: ethical and pragmatic considerations in the era of cosmetic neurology. J. Med. Ethics 2009, 35:611-615.
6. Maslen H., et al. The regulation of cognitive enhancement devices: Extending the medical model. J. Law Biosci. 2014, 1:68-93.
7. Farah M.J., et al. Cognitive enhancement. WIREs Cogn. Sci. 2014, 5:95-103.
8. World Health Organization Neurological Disorders: Public Health Challenges 2006, World Health Organization.